NCT04747431View on ClinicalTrials.gov

A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2031

Conditions
Frontotemporal DementiaFTDFTD-GRNDementia FrontotemporalC9orf72
Interventions
DRUG

PBFT02

PBFT02

Trial Locations (7)

19104

RECRUITING

University of Pennsylvania, Philadelphia

77030

RECRUITING

University of Texas at Houston, Houston

Unknown

RECRUITING

Hospital das Clinicas da Universidade Federal de Minas Gerais (UFMG), Minas Gerais

RECRUITING

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), São Paulo

RECRUITING

Centro Hospitalar e Universitário de Coimbra, Coimbra

M5T 2S8

RECRUITING

University of Toronto, Toronto Western Hospital, Toronto

H3A 2B4

RECRUITING

Montreal Neurological Institute-Hospital, Montreal

Sponsors

Lead Sponsor

Passage Bio, Inc.
All Listed Sponsors
lead

Passage Bio, Inc.

INDUSTRY